Fatty Liver  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00441272: Pioglitazone to Treat Fatty Liver in People With HIV Infection

Completed
2
100
US
Pioglitazone
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections, Hepatic Steatosis, Insulin Resistance
10/08
 
NCT00062764: Treating Nonalcoholic Steatohepatitis With Pioglitazone

Completed
2
18
US
Actos (Pioglitazone)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Hepatitis
02/09
02/09
NCT00633282: Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease

Completed
2
184
RoW
Life style intervention, calorie limited diet, aerobic exercise, pioglitazone, Actlns, PPAR agonist, Thiazolidinediones, insulin sensitizer, berberine, traditional Chinese medicine, herb
Xin Gao, Shanghai Jiao Tong University School of Medicine, Shanghai Municipal Science and Technology Commission
Nonalcoholic Fatty Liver Disease
08/11
08/11
NCT01703260: Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis

Terminated
2
20
US
Roflumilast, Daxas, Daliresp, Pioglitazone, Actos, Placebo
AstraZeneca
Nonalcoholic Steatohapatitis
09/14
09/14

Download Options